Medical Science Monitor · 2018 · 11 citations · 20 references
Surgical OncologyEngineeringPathologyTumor BiologyMagnetic Resonance ImagingOncologyCervical Cancer PatientsRadiation OncologyNuclear MedicineRadiologyMedical ImagingRadiation TherapyMir-18a LevelPredicting RadiosensitivityCervical Cancer CellsMri-guided Radiation TherapyTumor MicroenvironmentCervical CancerBiomedical ImagingMedicine
BACKGROUND Radioresistance during radiotherapy of cervical cancer often leads to treatment failure; therefore, there is an urgent need to develop effective predictive indicators of radiosensitivity for cervical cancer patients. MATERIAL AND METHODS Cervical cancer cells were collected from 40 patients who received surgical resections. The relationships between apparent diffusion coefficient (ADC) values of masses before surgery and different micro-RNAs (miRNA) levels (miR-18a, miR-132, and miR-145) of these cells were investigated. Cervical cancer cells were divided into 4 groups according to the ADC values of original tumor tissues and expression level of miR-18a. Then, these cells were exposed with irradiation both in vitro and in vivo. RESULTS Advanced cervical cancer showed lower ADC values in magnetic resonance imaging. miR-18a, miR-132, and miR-145 all were increased in the cervical cancer tissues, while miR-18a showed a more marked negative correlation with ADC values. The results of in vitro and in vivo assays showed that higher expression of miR-18a in cervical cancer cells leads to more radiosensitivity, especially in cells from cancer tissues with lower ADC values. CONCLUSIONS The combination of ADC values with expression level of miR-18a may be a new and reliable predictor for radiosensitivity of cervical cancer, helping cervical cancer patients with low ADC values and high expressions of miR-18a to achieve better outcomes in radiotherapy.
20
Guglielmo Ronco, Joakim Dillner, K. Miriam Elfström et al. · The Lancet · 2013 · 1.7K citations · Full text
Invasive Cervical Cancer, Cervical Cancer Screening, Cervical Cancer Management +15
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari, Michael W. Sill, Harry J. Long et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text
Debbie Saslow, Diane Solomon, Herschel W. Lawson et al. · CA A Cancer Journal for Clinicians · 2012 · 1.4K citations · Full text
The Pap Test and Bethesda 2014
Journal of the American Society of Cytopathology · 2015 · 1.1K citations